Knockdown of NG2 by siRNA results in decreased viability and a reduction in PARP levels. by Frank Maus (792209)

Diabetic wounds show increased amounts of vessel leakage and decreased pericyte coverage. by Uzoagu A. Okonkwo (8754933)

Herceptin down-regulates HER2 receptors and decreases HER3 phosphorylation, but it does not decrease HER2 phosphorylation. by Merel Gijsen (234741)

The Intracellular level of FLASH decreases during apoptosis. by Song Chen (69646)

Decreased osteoclast formation by LDH-A or LDH-B depletion. by Heejin Ahn (3173670)

(R+S) and (R)-albuterol decrease NF-κB activity by Marcela A Ferrada (41716)

(R)-albuterol decreases cytokine protein levels in activated T cells by Marcela A Ferrada (41716)

“…</p><p></p> (R)-albuterol, (S)-albuterol or racemic albuterol (R + S) at a dose (10M) were added to T (EL-4) cells pre-activated with mitogens Concanavalin A (Con A, 5 μg/ml) and phorbol myristate acetate (PMA, 100 ng/ml) (CP). …”

(R)-albuterol decreases cytokine levels in activated murine splenocytes by Marcela A Ferrada (41716)

“…</p><p></p> (R)-albuterol (R), (S)-albuterol (S) or racemic albuterol (R + S) at a dose (10M) were added to murine splenocytes pre-activated with mitogens Concanavalin A (Con A, 5 μg/ml) and phorbol myristate acetate (PMA, 100 ng/ml) (CP), (Fig 3 A, B). …”

2-APB decreased the cytokine secretions in human DC. by Romain Félix (586765)

IL-1Ra expressed by MSCs decreased Th17 differentiation. by Kijun Lee (4888660)

(R)-albuterol decreases cytokine mRNA levels in activated T cells by Marcela A Ferrada (41716)

“…</p><p></p> (R)-albuterol, (S)-albuterol or racemic albuterol (R + S) at a dose (10M) were added to T (EL-4) cells pre-activated with mitogens Concanavalin A (Con A, 5 μg/ml) and phorbol myristate acetate (PMA, 100 ng/ml) (CP). …”

h-GAAP Decreases Cell Susceptibility to Extrinsic Apoptosis Pathways by Caroline Gubser (24818)

2-APB decreased the expression of maturation markers in human DC. by Romain Félix (586765)

Cilostazol decreases OC formation and bone resorption induced by RANKL. by Ke Ke (583325)

Ca²⁺ and Ach decreased the release of VIP. by Nicholas Boulais (369327)

LPS dose-dependently decreases T cell proliferative response to OKT3. by Fanny Poujol (834338)

IFNγ decreases cell proliferation of NPCs via p21. by Johanna Mäkelä (223358)

“…(<b>G</b>) p53 gene deleted mouse embryonic fibroblasts were treated with 10–100 ng/ml IFNγ for 2 days and cell viability determined as described in <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0011091#s4" target="_blank">Methods</a>.…”

Inhibition of p53 expression decreases TRAIL receptor-induced apoptosis. by Anna Willms (6556340)

PRL decreased the proapoptotic ratio Bax/Bcl-2 in hippocampal neurons exposed with Glu. by Nadia A. Rivero-Segura (4006709)

IGFBP-3 decreases vascular tone by activating scavenger receptor-B1. by Yagna P. R. Jarajapu (316562)

“…A significant decrease in myogenic tone was observed at 100 (*P<0.02, n = 5) and 300 ng/ml (**P<0.01, n = 5) IGFBP-3. …”